Table 2.

Primary assessment.

Primary evaluation method: Overall assessment
Number of patients screened	68
Number of patients enrolled	62
Number of patients evaluated for toxicity	62
Number of patients evaluated for efficacy	62
Evaluation method	RECIST 1.1
Response assessment PR	n = 20
Response assessment SD	n = 37
Response assessment PD	n = 5
ORR	32.3% (20/62)
DCR	91.9% (57/62)
(Median) duration assessments PFS	8.4 months (95% CI: 3.6-10.4 months)